Quest Diagnostics Reaffirms 2025 Guidance
Quest Diagnostics has reaffirmed its guidance for 2025, projecting steady growth in revenue and earnings per share. Key highlights of the company’s guidance include:
- Revenue growth: steady
- Earnings per share (EPS) growth: steady
The company has outlined its strategic priorities to drive sustainable growth, focusing on:
- Expanding market access
- Achieving double-digit growth in advanced diagnostics
Quest Diagnostics has also highlighted its long-term outlook, expecting:
- 4-5% compound annual revenue growth beyond 2025
- 7-9% adjusted EPS growth beyond 2025
The company’s growth strategy is expected to deliver long-term shareholder value.